{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:31:55Z","timestamp":1751463115130},"reference-count":45,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/ijmm.2015.2245","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T04:01:14Z","timestamp":1434081674000},"page":"559-564","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells"],"prefix":"10.3892","volume":"36","author":[{"given":"XIAOFEN","family":"PAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GANG","family":"PENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHA","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZIYI","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHENWEI","family":"ZOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GANG","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"key":"key20180107232939_b1-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5732\/cjc.009.10329","article-title":"Is nasopharyngeal cancer really a \u2018Cantonese cancer\u2019?","volume":"29","author":"Wee","year":"2010","journal-title":"Chin J Cancer"},{"key":"key20180107232939_b2-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2009.11.024","article-title":"Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"79","author":"Ng","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"key20180107232939_b3-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2009.01.018","article-title":"Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience","volume":"75","author":"Tham","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"key20180107232939_b4-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11864-013-0261-5","article-title":"Current treatment options for local residual nasopharyngeal carcinoma","volume":"14","author":"Stoker","year":"2013","journal-title":"Curr Treat Options Oncol"},{"key":"key20180107232939_b5-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jnci\/djt072","article-title":"Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis","volume":"105","author":"Lee","year":"2013","journal-title":"J Natl Cancer I"},{"key":"key20180107232939_b6-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1634\/theoncologist.2008-0001","article-title":"Trastuzumab in the adjuvant treatment of early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Dahabreh","year":"2008","journal-title":"Oncologist"},{"key":"key20180107232939_b7-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107232939_b8-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","article-title":"Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: The M77001 study group","volume":"23","author":"Marty","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107232939_b9-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clcc.2014.06.004","article-title":"Adaptation of international guidelines for metastatic colorectal cancer: An asian consensus","volume":"13","author":"Cheng","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"key20180107232939_b10-ijmm-36-02-0559","article-title":"Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery","author":"Adachi","year":"2014","journal-title":"Surg Today"},{"key":"key20180107232939_b11-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hed.20792","article-title":"Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma","volume":"30","author":"Chua","year":"2008","journal-title":"Head Neck"},{"key":"key20180107232939_b12-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00280-007-0575-8","article-title":"A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy","volume":"62","author":"Ma","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107232939_b13-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2006.10.2871","article-title":"Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma","volume":"25","author":"Elser","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180107232939_b14-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1200\/JCO.2005.02.147","article-title":"Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma","volume":"23","author":"Chan","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107232939_b15-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/geno.1995.1020","article-title":"Human protein tyrosine phosphatase 1C (PTPN6) gene structure: Alternate promoter usage and exon skipping generate multiple transcripts","volume":"27","author":"Banville","year":"1995","journal-title":"Genomics"},{"key":"key20180107232939_b16-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygeno.2013.10.001","article-title":"Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells","volume":"102","author":"Evren","year":"2013","journal-title":"Genomics"},{"key":"key20180107232939_b17-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2478\/raon-2014-0001","article-title":"Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma","volume":"48","author":"Peng","year":"2014","journal-title":"Radiol Oncol"},{"key":"key20180107232939_b18-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3892\/mmr.2014.2463","article-title":"Alterations of cell cycle control proteins SHP-1\/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells","volume":"10","author":"Peng","year":"2014","journal-title":"Mol Med Rep"},{"key":"key20180107232939_b19-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1748-717X-8-178","article-title":"SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer","volume":"8","author":"Cao","year":"2013","journal-title":"Radiat Oncol"},{"key":"key20180107232939_b20-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"e84486","DOI":"10.1371\/journal.pone.0084486","article-title":"Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"key20180107232939_b21-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.ejca.2013.03.001","article-title":"MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B","volume":"49","author":"Li","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20180107232939_b22-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/onc.2012.574","article-title":"MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"key":"key20180107232939_b23-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","article-title":"miR-21-mediated tumor growth","volume":"26","author":"Si","year":"2007","journal-title":"Oncogene"},{"key":"key20180107232939_b24-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2014.09.001","article-title":"Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy","volume":"81","author":"Cheng","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"key20180107232939_b25-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/br.2013.109","article-title":"Serum microRNAs: A new diagnostic method for colorectal cancer","volume":"1","author":"Yang","year":"2013","journal-title":"Biomed Rep"},{"key":"key20180107232939_b26-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7150\/thno.7445","article-title":"Micro-RNAs as potential new molecular biomarkers in oncology: Have they reached relevance for the clinical imaging sciences?","volume":"3","author":"Berger","year":"2013","journal-title":"Theranostics"},{"key":"key20180107232939_b27-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-007-5590-1_1","article-title":"MicroRNAs in human cancer","volume":"774","author":"Farazi","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"key20180107232939_b28-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3747\/co.v16i4.486","article-title":"RNA interference and micro RNA-oriented therapy in cancer: rationales, promises, and challenges","volume":"16","author":"Duchaine","year":"2009","journal-title":"Curr Oncol"},{"key":"key20180107232939_b29-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/156800912802429355","article-title":"Promises and challenges of MicroRNA-based treatment of multiple myeloma","volume":"12","author":"Tagliaferri","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107232939_b30-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.7314\/APJCP.2014.15.17.6989","article-title":"MicroRNAs in colorectal cancer: from diagnosis to targeted therapy","volume":"15","author":"Orang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107232939_b31-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3892\/ijmm.2014.1937","article-title":"Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells","volume":"34","author":"Long","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20180107232939_b32-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/cas.12555","article-title":"miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro","volume":"105","author":"Li","year":"2014","journal-title":"Cancer Sci"},{"key":"key20180107232939_b33-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/cbr.2013.1596","article-title":"Influence of recombinant lentiviral vector encoding miR-15a\/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells","volume":"29","author":"Zhang","year":"2014","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180107232939_b34-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"e87767","DOI":"10.1371\/journal.pone.0087767","article-title":"Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"key20180107232939_b35-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2012.10.033","article-title":"MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy","volume":"329","author":"Zhang","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107232939_b36-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4161\/cc.11.4.19228","article-title":"MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN","volume":"11","author":"Qu","year":"2012","journal-title":"Cell Cycle"},{"key":"key20180107232939_b37-ijmm-36-02-0559","first-page":"1810","article-title":"Effects of radiosensitivity and X-ray dose on miR-7 expression in nasopharyngeal carcinoma","volume":"30","author":"Chen","year":"2010","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20180107232939_b38-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2014.09.004","article-title":"Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers","volume":"81","author":"Tong","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"key20180107232939_b39-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"12593","DOI":"10.1007\/s13277-014-2581-x","article-title":"MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14)","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumor Biol"},{"key":"key20180107232939_b40-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","article-title":"Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances","volume":"194","author":"Gandhi","year":"2014","journal-title":"J Control Release"},{"key":"key20180107232939_b41-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.186.9.1575","article-title":"Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes","volume":"186","author":"Delibrias","year":"1997","journal-title":"J Exp Med"},{"key":"key20180107232939_b42-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)62535-7","article-title":"Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas\/leukemias: combination analysis with cDNA expression array and tissue microarray","volume":"159","author":"Oka","year":"2001","journal-title":"Am J Pathol"},{"key":"key20180107232939_b43-ijmm-36-02-0559","first-page":"251","article-title":"A long survival case of small cell lung cancer synchronized with renal cancer","volume":"44","author":"Sato","year":"1991","journal-title":"Kyobu Geka"},{"key":"key20180107232939_b44-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.2178","article-title":"Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (SHP-1) is associated with progression of chronic myeloid leukaemia","volume":"212","author":"Amin","year":"2007","journal-title":"J Pathol"},{"key":"key20180107232939_b45-ijmm-36-02-0559","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/187152011794941154","article-title":"SHP-1 in cell-cycle regulation","volume":"11","author":"L\u00f3pez-Ruiz","year":"2011","journal-title":"Anticancer Agents Med Chem"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2015.2245\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:59:43Z","timestamp":1515351583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2015.2245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,6,12]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/ijmm.2015.2245"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2015.2245","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}